Discover the power of "triple-threat stocks" today!

Legendary investor, Tim Melvin, unearths overlooked "triple-threat stocks" in his Yield Report. Want a short at handsome opportunities in both a bear and bull market? See if you qualify for The Yield Report. Read the qualifications right here right now.

Analyst Stock Ratings Downgrades

Analyst downgrades are often a bearish signal for a stock. When an analyst downgrades a stock it means the stock rating is lower than it previously was and the analyst likely does not recommend people buy the stock. Updated 04/30/2024

date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert
04/30/2024SANMBuy Now
Sanmina
$61.221.27%Craig-Hallum
Christian Schwab76%
 → $62DowngradeBuy → HoldGet Alert
04/30/2024CHGGBuy Now
Chegg
$5.3830.23%Craig-Hallum
Alex Fuhrman42%
$13 → $7DowngradeBuy → HoldGet Alert
04/30/2024DCPHBuy Now
Deciphera Pharmaceuticals
$25.34—JMP Securities
Reni Benjamin54%
—DowngradeMarket Outperform → Market PerformGet Alert
04/30/2024CHGGBuy Now
Chegg
$5.38-25.58%Jefferies
Brent Thill78%
$7 → $4DowngradeHold → UnderperformGet Alert
04/30/2024PARABuy Now
Paramount Global
$11.71—Needham
Laura Martin71%
—DowngradeBuy → HoldGet Alert
04/30/2024BABuy Now
Boeing
$171.83—Argus Research
John Eade75%
—DowngradeBuy → HoldGet Alert
04/30/2024XPBuy Now
XP
$20.7310.98%Goldman Sachs
Tito Labarta49%
$30 → $23DowngradeBuy → NeutralGet Alert
04/30/2024GERNBuy Now
Geron
$3.9613.64%Baird
Joel Beatty71%
 → $4.5DowngradeOutperform → NeutralGet Alert
04/29/2024BHEBuy Now
Benchmark Electronics
$31.494.8%Sidoti & Co.
Anja Soderstrom56%
 → $33DowngradeBuy → NeutralGet Alert
04/29/2024DCPHBuy Now
Deciphera Pharmaceuticals
$25.341.05%JonesTrading
Soumit Roy30%
 → $25.6DowngradeBuy → HoldGet Alert
04/29/2024DCPHBuy Now
Deciphera Pharmaceuticals
$25.341.05%Jefferies
Eun Yang37%
$26 → $25.6DowngradeBuy → HoldGet Alert
04/29/2024SLBBuy Now
Schlumberger
$48.459.38%Wells Fargo
Chris Vole11%
$68 → $53DowngradeOverweight → Equal-WeightGet Alert
04/29/2024DESPBuy Now
Despegar.com
$12.1719.15%Citigroup
Joao Pedro Soares71%
$11.5 → $14.5DowngradeBuy → NeutralGet Alert
04/29/2024ACRVBuy Now
Acrivon Therapeutics
$9.70—Ladenburg Thalmann
Aydin Huseynov39%
—DowngradeBuy → NeutralGet Alert
04/29/2024ULTABuy Now
Ulta Beauty
$410.045.84%Barclays
Adrienne Yih70%
$612 → $434DowngradeOverweight → Equal-WeightGet Alert
04/29/2024LULUBuy Now
Lululemon Athletica
$360.629.53%Barclays
Adrienne Yih70%
$546 → $395DowngradeOverweight → Equal-WeightGet Alert
04/29/2024LUVBuy Now
Southwest Airlines
$26.22-23.72%Jefferies
Sheila Kahyaoglu71%
$28 → $20DowngradeHold → UnderperformGet Alert
04/29/2024ALTBuy Now
Altimmune
$6.49—Guggenheim
Seamus Fernandez64%
—DowngradeBuy → NeutralGet Alert
04/29/2024ERFBuy Now
Enerplus
$19.8410.89%RBC Capital
Greg Pardy67%
$21 → $22DowngradeOutperform → Sector PerformGet Alert

Recent Analyst Stock Rating Downgrades News

Craig-Hallum Downgrades Sanmina to Hold, Announces $62 Price Target
Craig-Hallum analyst Christian Schwab downgrades Sanmina (NASDAQ:SANM) from Buy to Hold and announces $62 price target.
Craig-Hallum Downgrades Chegg to Hold, Lowers Price Target to $7
Craig-Hallum analyst Alex Fuhrman downgrades Chegg (NYSE:CHGG) from Buy to Hold and lowers the price target from $13 to $7.
Paramount Could Be Worth $4 Or $14 Per Share In Deal, Analyst Says: 'We Prefer To Sit This One Out'
A short earnings call and lack of updates from Paramount has analysts questioning what's next and encouraging caution to investors.
JMP Securities Downgrades Deciphera Pharmaceuticals to Market Perform
JMP Securities analyst Reni Benjamin downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Market Outperform to Market Perform.
Jefferies Downgrades Chegg to Underperform, Lowers Price Target to $4
Jefferies analyst Brent Thill downgrades Chegg (NYSE:CHGG) from Hold to Underperform and lowers the price target from $7 to $4.
Needham Downgrades Paramount Global to Hold
Needham analyst Laura Martin downgrades Paramount Global (NASDAQ:PARA) from Buy to Hold.
Argus Research Downgrades Boeing to Hold
Argus Research analyst John Eade downgrades Boeing (NYSE:BA) from Buy to Hold.
Goldman Sachs Downgrades XP to Neutral, Lowers Price Target to $23
Goldman Sachs analyst Tito Labarta downgrades XP (NASDAQ:XP) from Buy to Neutral and lowers the price target from $30 to $23.
Baird Downgrades Geron to Neutral, Maintains $4.5 Price Target
Baird analyst Joel Beatty downgrades Geron (NASDAQ:GERN) from Outperform to Neutral and maintains $4.5 price target.
Sidoti & Co. Downgrades Benchmark Electronics to Neutral, Announces $33 Price Target
Sidoti & Co. analyst Anja Soderstrom downgrades Benchmark Electronics (NYSE:BHE) from Buy to Neutral and announces $33 price target.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free